Attached files

file filename
EX-32.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.d264862dex322.htm
EX-21.1 - SUBSIDIARIES - AVEO PHARMACEUTICALS, INC.d264862dex211.htm
EX-32.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 906 - AVEO PHARMACEUTICALS, INC.d264862dex321.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.d264862dex312.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO SECTION 302 - AVEO PHARMACEUTICALS, INC.d264862dex311.htm
EX-10.8 - FORM OF RESTRICTED STOCK AGREEMENT - AVEO PHARMACEUTICALS, INC.d264862dex108.htm
EX-10.25 - AMENDMENT NO. 1 TO LOAN & SECURITY AGREEMENT - AVEO PHARMACEUTICALS, INC.d264862dex1025.htm
EX-10.29 - FIRST AMENDMENT TO SUBLEASE - AVEO PHARMACEUTICALS, INC.d264862dex1029.htm
EX-10.23 - EXTENSION LETTER AMENDMENT - AVEO PHARMACEUTICALS, INC.d264862dex1023.htm
EXCEL - IDEA: XBRL DOCUMENT - AVEO PHARMACEUTICALS, INC.Financial_Report.xls
10-K - FORM 10-K - AVEO PHARMACEUTICALS, INC.d264862d10k.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-165530 and 333-175390 and Form S-3 Nos. 333-178756 and 333-174254) of AVEO Pharmaceuticals, Inc. and in the related Prospectus of our reports dated March 30, 2012, with respect to the consolidated financial statements of AVEO Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of AVEO Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.

/s/    ERNST & YOUNG LLP

Boston, Massachusetts

March 30, 2012